Top Industry News

The latest from CDMOs, CMOs, and suppliers featuring Simtra Biopharma, BioVectra, Kindeva, Ginkgo Bioworks, Polypeptide/Lifecore Biomedical, Ardena, WuXi Apptec and Symbiosis.   Chemicals/Chemical API Manufacturing * PolyPeptide, Lifecore Partner for End-to-End Peptide MfgBiologics…

A roundup of news from AstraZeneca, Teva Pharmaceuticals, Roche/Manifold Bio, Merck & Co./Blackstone Life Sciences, Boehringer Ingelheim/CDR-Life, Eli Lilly and Company/Ailux and Merck & Co./Dr Falk Pharma. Highlights below.   Mfg News *…

Novartis has agreed to acquire Avidity Biosciences, an RNA-focused bio/pharmaceutical company, for $12 billion to boost Novartis late-stage neuroscience pipeline.  Avidity is developing RNA therapeutics, antibody oligonucleotide conjugates (AOCs), for…

Eli Lilly and Company has announced a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.   This new…

The Board of Directors of Organon, the former women’s health, biosimilars and established brand business of Merck & Co., which was spun off as an independent company in 2021, has…

Novartis has completed its acquisition of Tourmaline Bio, a New York-based clinical-stage bio/pharmaceutical company, for $1.4 billion. The deal was announced in September 2025.   Tourmaline’s lead candidate is pacibekitug, an…

The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Lonza, SK pharmteco/Lotte Biologics, Hovione, Sai Life Sciences, BioCina, Alcami, Piramal Pharma/IntoCell and Roquette.   General * Thermo Fisher to Acquire…

A roundup of news from Eli Lilly and Company, GSK/Empirico, Regeneron, Nvidia, Lupin and Novavax. Highlights below.   Mfg News * Regeneron Gets FDA Complete Response Letter for Mfg Issues for HD…

The DCAT Summit at Lugano, “Expedition Pharma: Innovation from a Patient-First Perspective,” held June 4–5, 2025, in Lugano, Switzerland, concluded with a thought-provoking panel discussion that examined macro issues impacting…

Novo Nordisk announced this week (October 21, 2025) that the Board of Directors has decided to convene an Extraordinary General Meeting to elect new members of the company’s Board. In…